RCS - Cambridge Nutrition. - Scientific Educational Programme expanded

Cambridge Nutritional SciencesAnnouncement

04/12/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231204:nRSD4602Va&default-theme=true

RNS Number : 4602V  Cambridge Nutritional Sciences PLC  04 December 2023

 

CAMBRIDGE NUTRITIONAL SCIENCES PLC

("CNS" or the "Company" or the "Group")

 

CNS continues to expand Scientific Educational Programme and build
relationships at leading Industry Events

 

·    Company delivers latest webinar tackling the role of inflammation in
irritable bowel syndrome

·    Lecture presented in Dubai alongside one of India's key opinion
leaders on food sensitivity

·    CNS continues to raise its profile at key industry events, helping
drive demand for products

 

 

CNS (AIM: CNSL), the specialist medical diagnostics company focused on
promoting a personalised and functional approach to health and nutrition,
announces developments in its scientific education programme, a key initiative
which enables the Company to collaborate with a number of global and UK-based
key opinion leaders in the nutritional science field. CNS also highlights the
industry events attended recently as it continues its drive to build
relationships with healthcare practitioners as well as existing and
prospective business partners.

 

Latest Educational Webinar Released: "Inflammation in irritable bowel
syndrome: myth or new treatment target"

·    Thought-leading topic exploring how food IgG antibodies can activate
mast cells in the gut leading to irritable bowel syndrome symptoms.

·    In October, CNS's Scientific Director, Dr Nigel Abraham, presented
this lecture in person at the International Symposium for food intolerance and
Digestive Health ('FIDHC') in Dubai, alongside Mumbai based Dietician and
founder of FREEDOM Lifestyle and Wellness Centre, nutrition advisor to the
Indian Navy and key opinion leader on food sensitivity testing in India, Dr
Naaznin Husein.

 

CNS Raises Awareness with Practitioners Through Networking at Leading UK
Industry Conferences

Key to CNS's strategy of maintaining a leadership position is
building awareness with healthcare practitioners. These events give the
company the opportunity to meet and re-engage with practitioner customers as
well as those who are new to food sensitivity testing or taking their first
steps in clinical practice.

 

IHCAN 2023 Summit

·    CNS's UK team participated in both the November and June IHCAN 2023
summits, the UK's largest integrative health conference and expo held in
London.

·    Key industry event, attended by approximately 300 integrative health
practitioners and guest speakers from around the world.

·    Opportunity to explain the clinical utility for the Company's
products to future practitioners in the end stages of their training.

·    Platform to educate those interested in learning about how embedding
food sensitivity testing in their practice can help resolve gut related health
issues and improve patient care.

 

NMI, IPMC, and ION

·    The company also attended several other relevant UK nutrition
conferences: Nutritional Medicine Institute ('NMI') in October, the
Integrative & Personalised Medicine Congress ('IPMC') in June and the
Institute for Optimum Nutrition ('ION') Open Day.

CNS Builds Business Partner Relationships at Industry Trade Fair

Medica

·    In November the Company attended Medica in Germany. The event allowed
CNS to meet with existing business partners, whilst also providing the
opportunity to connect with potential new partners in currently untapped
territories for the Group.

 

Commenting, Jag Grewal, Chief Executive Officer, said:

"Collaboration with global and UK-based key opinion leaders in the nutritional
science field is one of CNS's core values and is a fundamental part of our
scientific education programme. As a pioneer in personalised health and
nutrition it is vital for us to be leading the way with webinars exploring
emerging aspects of science related to gut health, and attending key industry
events alongside these high-profile speakers.

 

"This engagement is critical in our drive to foster strong partnerships with
healthcare practitioners and potential business partners. It leads to better
awareness and understanding of the Company, which in turn creates demand for
our products, and helps cement the Group as a global thought leader in its
field."

 

Contacts:

 Cambridge Nutritional Sciences PLC                                     www.cnsplc.com (http://www.cnsplc.com)
 Jag Grewal, Chief Executive Officer                                    via Walbrook PR

 Cavendish Capital Markets Limited                                      Tel: 020 7220 0500
 Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance)
 Nigel Birks / Harriet Ward (ECM)

 Walbrook PR Limited                                                    Tel: 020 7933 8780 or omega@walbrookpr.com
 Paul McManus / Charlotte Edgar                                         Mob: 07980 541 893 / Mob: 07884 664 686 /
 Sam Allen                                                              Mob: 07502 558 258

About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical
diagnostics company focused on industry-leading Health and Nutrition products.

 

 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRANKDBNABDDFBK